Peptides in 2026, What the FDA Review Means Olympia Pharmaceuticals When will the FDA reclassify BPC 157 to Category 1 Octagon AI FDA Proposes to Exclude GLP 1s From 503B Bulk List Drug Topics BPC 157 Banned: Key Facts on the Latest FDA Decision FDA to Convene Pharmacy Compounding Advisory Committee in July The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York